Related Experiment Video
Updated: Jul 15, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Glycogen synthase kinase 3beta induces cell cycle arrest in a cyclin D1-dependent manner in human lung adenocarcinoma
Jian-Sha Li1, Min Zhu, Dan Tian
1Department of Pathology, Tongji Medical College, Huazhong University of Science and Technology, and Key Laboratory of Pulmonary Disease of Ministry of Health of China, Wuhan, China.
Abstract:
The effect of glycogen synthase kinase 3beta (GSK3beta) has been repeatedly implicated in cell proliferation, but studies on the effect of GSK3beta in different cell lines with different stimuli have drawn different conclusions. To investigate the direct effect of GSK3beta on cell growth in human lung adenocarcinoma cell line A549, we changed its activity by transient transfection with two kinds of GSK3beta mutant plasmids, constitutively active form S9A-GSK3beta and dominant negative form KM-GSK3beta. Twenty-four hours later, cell counting, flow cytometry and Western blot detection were made respectively. The results showed that enhancing GSK3beta activity caused a decrease in cell number, as well as a higher percentage of cells at G(1) phase. Further, the expression of cyclin D1 was down-regulated by GSK3beta. Taken together, our observations suggest that GSK3beta may induce G(1) cell cycle arrest in a cyclin D1-dependent fashion and therefore possibly plays a growth-inhibitory role in A549 cells.
Insights
Glycogen synthase kinase 3beta (GSK3beta) activity inhibits cell growth in lung cancer cells. Enhancing GSK3beta reduced cell numbers and promoted G1 cell cycle arrest, suggesting a growth-inhibitory role.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Glycogen synthase kinase 3beta (GSK3beta) is implicated in cell proliferation.
- Previous studies on GSK3beta's role in cell proliferation have yielded conflicting results across different cell lines and stimuli.
Purpose of the Study:
- To investigate the direct effect of GSK3beta on cell growth in the human lung adenocarcinoma cell line A549.
- To elucidate the mechanism by which GSK3beta influences cell cycle progression in A549 cells.
Main Methods:
- Transient transfection of A549 cells with constitutively active (S9A-GSK3beta) and dominant-negative (KM-GSK3beta) GSK3beta mutant plasmids.
- Cell counting, flow cytometry, and Western blot analysis were performed 24 hours post-transfection.
Main Results:
- Enhanced GSK3beta activity led to a significant decrease in A549 cell number.
- Increased GSK3beta activity resulted in a higher percentage of cells in the G1 phase of the cell cycle.
- The expression of cyclin D1 was downregulated by GSK3beta in A549 cells.
Conclusions:
- GSK3beta may induce G1 cell cycle arrest in A549 lung adenocarcinoma cells.
- This cell cycle arrest appears to be dependent on the regulation of cyclin D1 expression.
- GSK3beta potentially plays a growth-inhibitory role in A549 lung cancer cells.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...